非小細胞肺がん(NSCLC)治療薬の世界市場:市場、企業、研究開発展望...市場調査レポートについてご紹介

【英文タイトル】Non-Small Cell Lung Cancer Drugs: Market, Companies and R&D Outlook 2015-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Non-Small Cell Lung Cancer (NSCLC) Overview
1.2 Why You Should Read this Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Report for?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Reports
1.9 About Visiongain

2. Introduction to NSCLC and its Treatment
2.1 Lung Cancer is the Most Common Cancer, and NSCLC Accounts for 85%-90% of All Cases
2.2 The Three Main Histological Sub-Types of NSCLC
2.3 Genetic Mutations Allow for Targeted Therapies
2.4 Staging of NSCLC
2.5 Treatment Protocols by Stage
2.5.1 Stage 1 or 2
2.5.2 Stage 3
2.5.3 Stage 4: First Line-Therapy
2.5.3.1 Standard Chemotherapy Used to be the Only Treatment Option
2.5.3.2 Newer Therapies offers Improved Treatment Outcomes
2.5.3.3 Summary of First-Line Therapy Options: Un-Met Need in Squamous Patient Population
2.5.4 Maintenance Therapy
2.5.5 Second-Line and Third-Line Therapy

3. Leading NSCLC Drugs, 2015-2025
3.1 Alimta (pemetrexed) by Eli Lilly – The Leading NSCLC Therapy
3.1.1 Mechanism of Action
3.1.2 Three out of its Four FDA-Approved Indications are for NSCLC
3.1.3 Patent Expiries
3.1.3.1 ‘Method-Of-Use’ Vitamin Dosage Regimen Patent – Alimta’s Saviour from Generic Competition?
3.1.4 NICE Rejects Alimta for Maintenance Therapy
3.1.5 Total Alimta Revenues, 2010-2014
3.1.6 Alimta for NSCLC, 2014
3.1.7 Alimta for NSCLC Forecast, 2015-2025
3.2 Avastin (bevacizumab) – Roche’s Cancer Behemoth is a Leading Presence in NSCLC
3.2.1 Mechanism of Action
3.2.2 Multiple Approved Indications, but NSCLC was one of the First
3.2.3 Growing Discontent with Avastin in NSCLC – Is it Cost-Effective?
3.2.4 Total Avastin Revenues, 2010-2014
3.2.5 Avastin for NSCLC Forecast, 2015-2025
3.3 Tarceva (erlotinib) by Roche
3.3.1 Mechanism of Action
3.3.2 Three of Four Indications are for NSCLC
3.3.3 NICE Changes Mind on Tarceva – and then Changes it Back Again
3.3.4 Total Tarceva Revenues, 2010-2014
3.3.5 Tarceva for NSCLC Forecast, 2015-2025
3.4 Iressa (gefitinib) by AstraZeneca
3.4.1 Iressa Finally Returns to the Crucial US Market after Four Year Departure
3.4.2 Iressa NSCLC Revenues, 2010-2014
3.4.3 Iressa for NSCLC Forecast, 2015-2025
3.5 Gilotrif (afatinib) by Boehringer Ingelheim
3.5.1 Newcomer to the Market Rounds out the Trio of Currently Approved EGFR Inhibitors
3.5.2 Gilotrif Displays Significant Survival Benefit over Tarceva in Squamous Setting
3.5.3 Gilotrif for NSCLC Forecast, 2015-2025
3.6 Xalkori (crizotinib) by Pfizer
3.6.1 Mechanism of Action
3.6.2 The First Approved ALK Inhibitor
3.6.3 Co-Promotion with Merck KGaA, and has Treated Over 8,000 Patients
3.6.4 Xalkori NSCLC Revenues, 2012-2014
3.6.5 Xalkori for NSCLC Forecast, 2015-2025
3.7 Abraxane (paclitaxel Protein-Bound) by Celgene
3.7.1 Mechanism of Action
3.7.2 Relatively Recent Approval for NSCLC Indication
3.7.3 Finally Approved for NSCLC in the EU
3.7.4 Total Abraxane Revenues, 2010-2014
3.7.5 Abraxane for NSCLC Forecast, 2015-2025
3.8 Taxotere (docetaxel) by Sanofi
3.8.1 Mechanism of Action and Approved Indications
3.8.2 Sanofi Unable to Prevent Generics, Despite Appeal
3.8.3 Total Taxotere Revenues, 2010-2014
3.8.4 Taxotere for NSCLC Forecast, 2015-2025
3.9 Cyramza (ramucirumab) by Eli Lilly
3.9.1 Mechanism of Action
3.9.2 Many Approvals in Quick Succession
3.9.3 Cyramza for NSCLC Forecast, 2015-2025
3.10 Gemzar (gemcitabine) by Eli Lilly
3.11 Zykadia (ceritinib) by Novartis
3.11.1 Mechanism of Action and Recent Approval
3.11.2 Zykadia for NSCLC Forecast, 2015-2025
3.12 Opdivo (nivolumab) by Bristol-Myers Squibb
3.12.1 Mechanism of Action – Works With the Immune System to Fight Cancers
3.12.2 Swift Approvals through FDA Priority Review Programmes
3.12.3 Good News and Bad News for NSCLC from CheckMate Trials
3.12.4 Opdivo for NSCLC Forecast, 2015-2025

4. NSCLC R&D Pipeline, 2015-2025
4.1 Alecensa (alectinib) by Roche
4.1.1 Japan Becomes First Country to Approve and Launch Alectinib
4.1.2 Roche is Inching Closer Towards the All-Important US Approval
4.1.3 Four Ongoing Clinical Trials involving Alectinib in NSCLC
4.1.4 Japanese Revenues and Future Outlook
4.2 Vargatef (nintedanib) by Boehringer Ingelheim
4.2.1 EU Becomes First Region to Approve Vargatef
4.2.2 NICE has a Change of Heart on Vargatef
4.2.3 Ongoing Clinical Trials Involving Vargatef in NSCLC
4.3 AZD9291 by AstraZeneca
4.3.1 Regulatory Filings in the US and EU, Expected Times for Filings in Japan and China
4.3.2 Collaboration with Roche to Develop Companion Diagnostic
4.3.3 Positive Preliminary Results Presented at ASCO 2015
4.3.4 Ongoing Clinical Trials Involving AZD9291 in NSCLC
4.4 Rociletinib (CO-1686) by Clovis Oncology
4.4.1 In a Race to Approval Against AZD9291
4.4.2 Results So Far Have not Distinguished it Enough from Main Rival
4.4.3 Four Ongoing Clinical Trials Involving Rociletinib in NSCLC
4.5 Keytruda (pembrolizumab) by Merck (MSD)
4.5.1 Has Been Approved for Melanoma, NSCLC is one of the Next Major Targets
4.5.2 Ongoing Clinical Trials Involving Keytruda in NSCLC
4.6 Ganetespib (STA-9090) by Synta Pharmaceuticals
4.6.1 Ganetespib Mechanism of Action
4.6.2 Three Ongoing Clinical Trials Involving Ganetespib in NSCLC
4.7 Halaven (eribulin) by Eisai
4.7.1 Halaven Mechanism of Action
4.7.2 Clinical Trials Involving Halaven in NSCLC
4.8 Necitumumab by Eli Lilly
4.8.1 Phase 3 Results Show Modest Benefits and Worrying Adverse Event Profile
4.8.2 Eli Lilly has Filed for Approval in US and EU, and Verdict is Likely to be Positive, Despite Reservations
4.8.3 Ongoing Clinical Trials Involving Necitumumab in NSCLC
4.9 Atezolizumab (MPDL3280A) by Roche
4.9.1 Mechanism of Action
4.9.2 Atezolizumab Doubles Likelihood of Survival in Certain Subset of Patients
4.9.3 Six Ongoing Clinical Trials Involving Atezolizumab in NSCLC

5. Global NSCLC Market, 2015-2025
5.1 The Global NSCLC Market Forecast, 2015-2025
5.2 What Factors will Drive Growth in the Global NSCLC Market?
5.3 Growing Ageing Population
5.4 The Identification of Biomarkers for Targeted Therapies
5.5 Dynamic and Lucrative Sector with Strong Pipeline
5.6 Satisfying the Large Un-Met Need that is Treatment for Squamous Patients
5.7 What Factors will Restrain Growth in the Global NSCLC Market?
5.8 Patent Expiries and Generic Erosion will be the Main Detriment to the Market
5.9 New Therapies That Reportedly Offer Only Modest Benefits Over Existing Treatments
5.10 Declining Healthcare Budgets lead to Cost Pressures, and Resistance to Therapies is another Issue
5.11 SWOT Analysis of the Global NSCLC Market

6. Leading Therapeutic Segments and National Markets within the Global NSCLC Market
6.1 Therapeutic Composition of the Market in 2015 Compared to 2025
6.1.1 Therapeutic Segments Forecast, 2015-2025
6.1.2 Chemotherapy Segment Forecast, 2015-2025
6.1.3 EGFR and ALK Inhibitors Segment Forecast, 2015-2025
6.1.4 VEGF / VEGFR Inhibitors Segment Forecast, 2015-2025
6.1.5 Immunotherapy Segment Forecast, 2015-2025
6.2 Leading National Markets for NSCLC
6.2.1 Regional Composition of the Global Market in 2015, Compared to 2025
6.2.2 Leading Regional Markets for NSCLC Forecast, 2015-2025
6.2.3 US NSCLC Market, 2015-2025
6.2.3.1 Experiencing Some Changes, but Will Retain Dominance Throughout Forecast Period
6.2.3.2 US NSCLC Market Forecast, 2015-2025
6.2.4 EU5 NSCLC Market, 2015-2025
6.2.4.1 German NSCLC Market: Leader in EU, but Facing Big Reforms
6.2.4.2 German NSCLC Market Forecast, 2015-2025
6.2.4.3 French NSCLC Market: Strong National Healthcare System, Despite Economic Woes
6.2.4.4 French NSCLC Market Forecast, 2015-2025
6.2.4.5 Italian NSCLC Market
6.2.4.6 Italian NSCLC Market Forecast, 2015-2025
6.2.4.7 UK NSCLC Market: Pricing is a Key Issue, Providing Restraints to Revenues
6.2.4.8 UK NSCLC Market Forecast, 2015-2025
6.2.4.9 Spanish NSCLC Market
6.2.4.10 Spanish NSCLC Market Forecast, 2015-2025
6.2.5 Japanese NSCLC Market
6.2.5.1 Expansion of the Generics Market is a Key Factor
6.2.5.2 Japanese NSCLC Market Forecast, 2015-2025
6.2.6 BRIC NSCLC Market, 2015-2025
6.2.6.1 China NSCLC Market: Rapid Growth Will Make it one of the Major Global Players
6.2.6.2 China NSCLC Market Forecast, 2015-2025
6.2.6.3 Brazilian NSCLC Market: Taken Great Strides Forward with Healthcare
6.2.6.4 Brazilian NSCLC Market Forecast, 2015-2025
6.2.6.5 Russian NSCLC Market: Punches Below its Weight
6.2.6.6 Russian NSCLC Market Forecast, 2015-2025
6.2.6.7 Indian NSCLC Market: Generics are King
6.2.6.8 Indian NSCLC Market Forecast, 2015-2025

7. Research Interview
7.1 Interview with Novartis
7.1.1 On the Need for More than one ALK Inhibitor on the Market
7.1.2 Main Trends and Opportunities for NSCLC
7.1.3 The Present and the Future

8. Conclusions from Our Research and Analysis
8.1 How Will Revenues Change over the Forecast Period?
8.2 How will the Therapeutic Composition of the Market Change over the Forecast Period?
8.3 How Will the National Composition of the Global Market Change Over the Forecast Period?
8.4 Concluding Remarks


【レポート販売概要】

■ タイトル:非小細胞肺がん(NSCLC)治療薬の世界市場:市場、企業、研究開発展望
■ 英文:Non-Small Cell Lung Cancer Drugs: Market, Companies and R&D Outlook 2015-2025
■ 発行日:2015年10月
■ 調査会社:visiongain
■ 商品コード:VGAIN5112511
■ 調査対象地域:グローバル
  • スプリンクラー設備の世界市場:湿式スプリンクラー、乾式スプリンクラー、予作動式スプリンクラー、放水型スプリンクラー
    Fire sprinkler systems play a vital role in reducing the risk of fire in commercial, industrial, and residential buildings. These systems are being increasingly installed in several sectors as they systems are capable of detecting, restricting, and extinguishing fires in the early stages. There are different types of fire sprinkler systems which are used as per the different applications of variou …
  • 世界のETBE(エチル・ターシャリー・ブチル・エーテル)市場2015
    The Global Ethyl Tertiary Butyl Ether (ETBE) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Ethyl Tertiary Butyl Ether (ETBE) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Ethyl Tertiary Butyl Ether (ETBE) market analysis is provided for the …
  • 航空機健全性モニタリングシステム(AHMS)の世界市場:予知、診断、状態監視保全(CBM)、適応制御
    The aircraft health monitoring systems (AHMS) market is estimated at USD 3.43 Billion in 2016, and is projected to reach USD 4.71 Billion by 2021, at a CAGR of 6.53% from 2016 to 2021. Increase in situational awareness to drive operations, cost effective maintenance, and increase in asset utilization, and increasing volume of data generated to analyze aviation industry among others are some of the …
  • 世界のセラミックコーティング市場:Global Ceramic Coating Market 2014-2018
    TechNavio's analysts forecast the Global Ceramic Coating market to grow at a CAGR of 7.24 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in ceramic coating of automotive components. The Global Ceramic Coating market has also been witnessing the increasing use of plasma-sprayed ceramic coating. However, the high total cost of ownership c …
  • 照明の世界市場 :一般照明、自動車照明、バックライト
    About LightingLighting may be defined as all forms of illumination that are used to see an object, person, or the surrounding. In general lighting, we see the world around us. In automotive lighting, we see the roads and paths when driving, and in backlighting, we see the illumination from behind used in display technology and devices. Technavio’s analysts forecast the global lighting market to gr …
  • Saudi ArabiaのHydrogen Fluoride (Hydrofluoric Acid)市場:貿易(輸入、輸出)動向
    This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for Hydrogen fluoride (hydrofluoric acid). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Hydrogen fluoride (hydrofluoric acid) export/import operations i …
  • 世界のCNGコンプレッサ市場2015
    The Global CNG Compressor Industry 2015 Market Research Report is a professional and in-depth study on the current state of the CNG Compressor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The CNG Compressor market analysis is provided for the international markets including development trends, compe …
  • 油圧ユニットの世界市場
    The Hydraulic Power Unit (HPU) is an integrated package comprising hydraulic motor, hydraulic pump, and reservoir/accumulators along with other accessories such as valves, tubes, filter, regulators, and instruments to monitor the performance of a unit. It is used to transmit, control, and distribute energy from a pressurized fluid to perform various mechanical tasks. It is the main component of hy …
  • Canadian Oil Sands Limited:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
  • 自動車用燃料噴射装置の世界市場2016-2020
    Technavio market research analysts estimate the global market for automotive fuel injectors to post a moderate CAGR of approximately 3% by 2020. The growing need to control vehicle emissions and to increase the overall fuel efficiency of automobiles is expected to impel the adoption of fuel injectors in the automotive industry during the forecast period. The advent of stringent fuel economy and em …
  • ラピッドプロトタイピング(RP)材料の世界市場予測(~2021年):ポリマー、金属、セラミックス
    The rapid prototyping materials market was valued at USD 217.5 Million in 2015 and is projected to reach USD 903.8 Million by 2021, at a CAGR of 26.8% between 2016 and 2021. Major factors driving the growth of the rapid prototyping materials market include high demand for product modification and development, low cycle time of printing, expected increase in supply capacity with forward integration …
  • 量子カスケードレーザ(QCL)の世界市場予測(~2022年)
    “Quantum cascade lasers market to grow at a CAGR of 3.9% during the forecast period”According to the new market research report on quantum cascade lasers (QCL), this market is expected to be worth USD 374.8 million by 2022, growing at a CAGR of 3.9% between 2017 and 2022. The growth of the QCL market can be attributed to the growing application of QCL in gas sensing and chemical detection in indus …
  • 逆浸透膜(RO膜)の世界市場2015-2019
    About Reverse Osmosis Membranes Reverse Osmosis is a technology that uses a semi-permeable membrane to remove dissolved salts or organic molecules. The water is pushed under pressure through the membrane, which allows the passage of water molecules but prevents the dissolved salts and bacteria to pass through. A high-pressure pump is used to apply the required pressure for carrying out the process …
  • 世界の発泡ポリプロピレン材料市場
    About Polypropylene Foams Polypropylene foams are engineering plastic materials with unique material properties such as energy absorption, structural strength, thermal insulation, acoustical properties, and chemically inert; these foams are recyclable and lightweight in nature. Polypropylene foams are manufactured by the catalytic polymerization of propylene. The exclusive properties of this mater …
  • Denbury Resources Inc.:石油・ガスバリューチェーン分析レポート2013
    Denbury Resources Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Denbury Resources Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Denbury Resources Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。